DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Online

Impact of Ukraine Crisis on Patients and Clinical Development

This webinar will bring provocative discussion and highlight solutions to the ongoing crisis in Ukraine.

Presenters

Teresa  Lamantia, MSN, RN

Teresa Lamantia, MSN, RN

Senior Vice President, Operational Transformation & Performance, IQVIA, United States

Teresa Lamantia is Sr. Vice President, Operational Transformation and Performance at IQVIA, the world’s largest CRO and healthcare data science company. In this role she oversees the metrics and reporting team as well as the lifecycle transition management team for research and development solutions. She also serves as the global head of the COVID-19 Task Force. Prior to taking this role she serves as the head of Global Quality and Transformation, for Q2 Solutions, IQVIA laboratories, established in 2016. In this role she oversaw global quality assurance and transformation activities including continuous improvement, operational excellence, and integration/transformation strategic deliverables.

Bettina  Ryll

Bettina Ryll

Member of the First EU Cancer Mission Board, MPNE, Vision Zero Cancer, Sweden

Bettina Ryll, MD/PhD founded the Melanoma Patient Network Europe in 2013 and developed a special interest in patient-centric clinical research and drug development. Bettina’s current areas of focus are Adaptive Licensing/ MAPPS , innovative sustainable healthcare models and patient-centered risk/ benefit assessment tools. She lectures and advises on patient-centric drug development, member of ASCO and ISPOR and current chair of the ESMO Patient Advocacy Working Group.

Anna  Titkova, MD, PhD, MBA

Anna Titkova, MD, PhD, MBA

Country Head, Pratia Ukraine, Ukraine

Anna graduated from Kharkiv National Medical University. She has a PhD, Master of Medical Sciences, is an Associate Professor and works as a cardiologist and researcher at the Kharkiv Medical Academy of Postgraduate Education. She has an MBA and a master’s degree in pedagogy, completed an internship at Harvard and Yale Universities, and is a qualified International lecturer and senior researcher. In 2014, she started her career in the clinical research industry. In March 2020, Anna opened the Pratia Ukraine LLC and SMO clinical research site, Pratia Clinic Ukraine, part of the international site network Pratia under the umbrella of the NEUCA group. Her company works with 10 medical institutions in 3 Ukrainian regions in clinical trials.

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。